The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

被引：0
|
作者：
Tomasovic, A. [1 ]
Kramer, S. [1 ]
Huemmert, M. [1 ]
Katus, Ha [2 ]
Mueller, O. [2 ]
Lorenz, K. [3 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany
[2] Univ Hosp Heidelberg, Internal Med 3, Heidelberg, Germany
[3] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [41] IGF-1 REGULATES CARDIAC HYPERTROPHY AND INOS EXPRESSION IN OBESE MALE RATS THROUGH ERK1/2 SIGNALING PATHWAY
    Panic, A.
    Stanimirovic, J.
    Obradovic, M.
    Sudar-Milovanovic, E.
    Isenovic, E. R.
    ATHEROSCLEROSIS, 2018, 275 : E137 - E137
  • [42] Inhibition of ERK1/2 Worsens Intestinal Ischemia/Reperfusion Injury
    Ban, Kechen
    Peng, Zhanglong
    Kozar, Rosemary A.
    PLOS ONE, 2013, 8 (09):
  • [43] Activation of ERK1/2 in cardiac failure due to volume overload
    Sentex, E
    Zhang, W
    Wang, M
    Dhalla, NS
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A108 - A108
  • [44] ERK1/2: An Integrator of Signals That Alters Cardiac Homeostasis and Growth
    Gilbert, Christopher J.
    Longenecker, Jacob Z.
    Accornero, Federica
    BIOLOGY-BASEL, 2021, 10 (04):
  • [45] Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyoctes
    Mishra, Sumita
    Chatterjee, Subroto
    FASEB JOURNAL, 2014, 28 (01):
  • [46] Non-Genomic ERK1/2 Activation and Integrin αvβ3 Contribute to Cardiac Hypertrophy Induced by Thyroid Hormone
    Lino, Caroline
    Diniz, Gabriela
    Moreno, Camila
    Barreto-Chaves, Maria Luiza
    FASEB JOURNAL, 2015, 29
  • [47] Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
    Qi, Jianyong
    Liu, Qin
    Gong, Kaizheng
    Yu, Juan
    Wang, Lei
    Guo, Liheng
    Zhou, Miao
    Wu, Jiashin
    Zhang, Minzhou
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [48] Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes
    Sumita, Mishra
    Subroto, Chatterjee
    Subroto, Chatterjee
    GLYCOBIOLOGY, 2014, 24 (06) : 518 - 531
  • [49] Activation Of Erk1/2 Signaling Drives Cardiac Hypertrophy During Chronic Mild Stress-induced Depression In Mice
    Singh, Sarojini
    Patil, Mallikarjun
    Dubey, Praveen
    Dubey, Shubham
    Luong, Hien
    Krishnamurthy, Prasanna
    STROKE, 2022, 53
  • [50] Targeting of ERKThr188 phosphorylation attenuates cardiac hypertrophy but preserves the anti-apoptotic effects of ERK1/2
    Ruppert, C.
    Vidal, M.
    Lohse, M. J.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 77 - 77
12345